Glimepiride/pioglitazone

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

FCPR03 is a potent and selective phosphodiesterase 4 (PDE4) inhibitor with IC 50 values of 60 nM, 31 nM and 47 nM for PDE4 catalytic domain , PDE4B1 and PDE4D7 , respectively. FCPR03 displays at least 2100-fold selectivity over other PDEs (PDE1-3

InformationA unique collection of 3034 approved drugs for high throughput screening (HTS) and high content screening (HCS).Description &amp Advantages• A unique collection of 3035 approved drugs for high throughput screening (HTS) and high content

Synonym(s): Glp-Gly-Val-Asn-Asp-Asn-Glu-Glu-Gly-Phe-Phe-Ser-Ala-Arg Formula: C66H93N19O25 Formula weight: 1552.55 Harmonized Tariff Code:  2933.79

The PSMA/GCPII antibody from Proteintech is a Rabbit Polyclonal antibody to a Recombinant Protein of human PSMA/GCPII. This antibody recognizes Human, Mouse, Rat antigen.

Potent, cell permeable adenylyl cyclase activator. Increases intracellular cAMP levels.

Potent, cell permeable adenylyl cyclase activator. Increases intracellular cAMP levels.

Potent, cell permeable adenylyl cyclase activator. Increases intracellular cAMP levels.

FTase Inhibitor II is a potent farnesyl transferase inhibitor. The compound prevents the farnesylation of Ras, which results in Ras's inability to associate with other cell signaling components.

FTase Inhibitor II is a potent farnesyl transferase inhibitor. The compound prevents the farnesylation of Ras, which results in Ras's inability to associate with other cell signaling components.

FTase Inhibitor II is a potent farnesyl transferase inhibitor. The compound prevents the farnesylation of Ras, which results in Ras's inability to associate with other cell signaling components.